<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="editorial" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Virulence</journal-id><journal-id journal-id-type="iso-abbrev">Virulence</journal-id><journal-id journal-id-type="pmc-domain-id">1371</journal-id><journal-id journal-id-type="pmc-domain">viru</journal-id><journal-id journal-id-type="publisher-id">KVIR</journal-id><journal-id journal-id-type="publisher-id">kvir20</journal-id><journal-title-group><journal-title>Virulence</journal-title></journal-title-group><issn pub-type="ppub">2150-5594</issn><issn pub-type="epub">2150-5608</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7000210</article-id><article-id pub-id-type="pmcid-ver">PMC7000210.1</article-id><article-id pub-id-type="pmcaid">7000210</article-id><article-id pub-id-type="pmcaiid">7000210</article-id><article-id pub-id-type="pmid">29144201</article-id><article-id pub-id-type="doi">10.1080/21505594.2017.1395544</article-id><article-id pub-id-type="publisher-id">1395544</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Brucella</italic> Lipopolysaccharide and pathogenicity: The core of the matter</article-title><alt-title alt-title-type="running-authors">J. A. SMITH</alt-title><alt-title alt-title-type="running-title">VIRULENCE</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="JA">Judith A.</given-names></name><xref ref-type="aff" rid="af0001"/><xref ref-type="corresp" rid="an0001"/></contrib><aff id="af0001"><institution>University of Madison School of Medicine and Public Health</institution>, Madison WI</aff></contrib-group><author-notes><corresp id="an0001"><bold>CONTACT</bold> Judith A. Smith <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jsmith27@wisc.edu">jsmith27@wisc.edu</email><institution>University of Madison School of Medicine and Public Health</institution>, Madison WI 53792</corresp></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>1</day><month>3</month><year>2018</year></pub-date><volume>9</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">312982</issue-id><fpage seq="39">379</fpage><lpage>382</lpage><history><date date-type="received"><day>13</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>19</day><month>02</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-12-11 10:56:21.950"><day>11</day><month>12</month><year>2020</year></date></event></pub-history><permissions><copyright-statement>&#169; 2018 The Author. Published by Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>The Author</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="kvir-09-01-1395544.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="kvir-09-01-1395544.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary-article" xml:lang="en" xlink:title="research-article" journal-id="Virulence" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC5955181"><article-title>Immunomodulatory properties of <italic toggle="yes">Brucella melitensis</italic> lipopolysaccharide determinants on mouse dendritic cells <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic></article-title><volume>9</volume><issue>1</issue><date><day>2</day><month>10</month><year>2017</year></date><fpage seq="48">465</fpage><lpage>479</lpage><source>Virulence</source><pub-id pub-id-type="doi">10.1080/21505594.2017.1386831</pub-id><pub-id pub-id-type="pmcid">PMC5955181</pub-id><pub-id pub-id-type="pmid">28968180</pub-id></related-article><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Brucella</kwd><kwd>Lipopolysaccharide</kwd><kwd>LPS</kwd><kwd>Virulence factors</kwd><kwd>Dendritic cells</kwd><kwd>cytokines</kwd><kwd>vaccine</kwd><kwd>Bacteria</kwd><kwd>Gram negative</kwd><kwd>Host-pathogen interactions</kwd><kwd>Immune responses</kwd><kwd>Immunity innate</kwd><kwd>Virulence factors</kwd></kwd-group><funding-group><award-group><funding-source><named-content content-type="funder-name">NIH-NIAID</named-content></funding-source><award-id>R01 AI116453</award-id><award-id>R01 AI073558-08</award-id></award-group><funding-statement>Funding Source: NIH-NIAID ID: R01 AI116453 Funding Source: NIH-NIAID ID: R01 AI073558-08</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="40"/><page-count count="4"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Brucellosis is one of the most prevalent zoonotic infections worldwide.<xref rid="cit0001" ref-type="bibr"><sup>1</sup></xref> The half million reported new cases per year likely represents a gross underestimate related to challenges in diagnosis and incomplete reporting. In humans, brucellosis initially manifests as undulating fever accompanied by flu-like myalgias and arthralgias. However, chronic infection may lead to peripheral arthritis, sacroiliitis, orchitis, endocarditis and neurobrucellosis.<xref rid="cit0001" ref-type="bibr"><sup>1,2</sup></xref> Treatment involves prolonged courses of multiple antibiotics and relapses occur in up to 10% of patients.<xref rid="cit0003" ref-type="bibr"><sup>3</sup></xref> The causative agents, <italic toggle="yes">Brucella</italic> species, are Gram-negative facultative intracellular bacteria which infect herd animals such as goats, cattle and swine. In animals, <italic toggle="yes">Brucella</italic> species cause abortion, resulting in tremendous economic losses. Although animal vaccine strains such as Rev1, RB51 and S19 have been effective at controlling disease in the herds of nations with sufficient infrastructure and regulation, <italic toggle="yes">Brucella</italic> infections remain intractable in many parts of the world:<xref rid="cit0004" ref-type="bibr"><sup>4</sup></xref> Brucellosis is endemic in Central and South America, Sub-Saharan Africa, the Middle East and Asia.<xref rid="cit0005" ref-type="bibr"><sup>5</sup></xref>
<italic toggle="yes">Brucella</italic> are primarily transmitted to human hosts by ingestion of contaminated unpasteurized dairy products, but <italic toggle="yes">Brucella</italic> also poses a risk to herders and abattoir workers. Because of the low number needed for infection (10-100 organisms), and ready aerosolization, <italic toggle="yes">Brucella</italic> is considered a bioterror threat.<xref rid="cit0006" ref-type="bibr"><sup>6</sup></xref> Current vaccine strains cause disease in humans.<xref rid="cit0007" ref-type="bibr"><sup>7&#8211;9</sup></xref> Thus at present, no safe and effective human vaccine exists.</p><p>With the goal of improving therapeutic and vaccine strategies, research has focused on understanding the pathogenic determinants that allow <italic toggle="yes">Brucella</italic> to establish successful chronic infections and evade immune eradication. Ultimately, immune control of <italic toggle="yes">Brucella</italic> involves the development of effective Th1 cellular immunity.<xref rid="cit0010" ref-type="bibr"><sup>10,11</sup></xref> However, mobilization of <italic toggle="yes">Brucella</italic>-responsive T cells first requires recognition by &#8220;sentinel&#8221; dendritic cells of the innate immune system, and activation of these cells to become effective antigen presenting cells.<xref rid="cit0012" ref-type="bibr"><sup>12</sup></xref> Innate immune cells detect pathogens via repeated cellular patterns (PAMPs) such as the Lipopolysaccharide (LPS) coat on Gram-negative bacteria. Intriguingly, one of the major <italic toggle="yes">Brucella</italic> virulence factors identified to date is its non-canonical LPS.<xref rid="cit0013" ref-type="bibr"><sup>13</sup></xref></p><p>LPS plays a vital role in the integrity of Gram-negative bacterial outer membranes. It comprises three regions: a Lipid A moiety composed of a disaccharide backbone linked to up to seven hydrophobic acyl chains that are embedded in the outer membrane, a species-conserved core polysaccharide linker, and the external most O-polysaccharide chain.<xref rid="cit0014" ref-type="bibr"><sup>14</sup></xref> The inner core contains unusual sugars (e.g. 3-deoxy-D-manno-octulosonic acid (Kdo)), but the outer core has more common sugars such as hexoses and hexosamines. The O-polysaccharide, a long chain of repeating glycosyl subunits, exhibits the most variability, providing the means for strain differentiation in labs and antigenic stimulation of humoral immune responses. Innate immune cells recognize LPS via a heteromeric receptor composed of Toll-like receptor 4 (TLR4) and its binding partner myeloid differentiation-2 (MD2). MD2 contains a large hydrophobic pocket that accompanies 5 of the Lipid A acyl chains, whereas the LPS polysaccharide forms polar interactions with the rim of MD2 and TLR4.<xref rid="cit0015" ref-type="bibr"><sup>15,16</sup></xref> Agonist activity (endotoxicity) is generally thought to reflect the acyl chain number, length, and chemical modifications.<xref rid="cit0014" ref-type="bibr"><sup>14</sup></xref></p><p><italic toggle="yes">Brucella</italic> LPS counters innate immune defenses on multiple levels: the Lipid A moiety contains overly long C16-18 fatty acids (including up to C28), rather than the optimal 12&#8211;14 carbons, correlating with poor MD2 binding and low endotoxicity.<xref rid="cit0013" ref-type="bibr"><sup>13,17&#8211;19</sup></xref> The Lipid A component also kills neutrophils through an unclear mechanism.<xref rid="cit0020" ref-type="bibr"><sup>20</sup></xref> The O-polysaccharide resists complement deposition and activation.<xref rid="cit0021" ref-type="bibr"><sup>21</sup></xref> Inside cells, this outer polysaccharide is also important for evasion of lysosomal destruction. Indeed &#8220;rough&#8221; strains or mutants of <italic toggle="yes">Brucella</italic> lacking the external O-polysaccharide display significantly attenuated virulence.<xref rid="cit0022" ref-type="bibr"><sup>22,23</sup></xref> More recently the core moiety of <italic toggle="yes">Brucella</italic> has come to the fore as a key modulator of virulence.<xref rid="cit0019" ref-type="bibr"><sup>19</sup></xref> The <italic toggle="yes">Brucella</italic> core polysaccharide contains 2&#160;Kdo sugars; one connects to the O-polysaccharide, and the other to an unusual branching side chain.<xref rid="cit0024" ref-type="bibr"><sup>24,25</sup></xref> This side chain, with its positive charges, is thought to &#8220;shield&#8221; the more internal negative charges from effective interaction with the MD2/TLR4 receptor.<xref rid="cit0019" ref-type="bibr"><sup>19,24</sup></xref>
<italic toggle="yes">Brucella</italic> mutants deficient in the <italic toggle="yes">wadC</italic> mannosyltransferase enzyme required for this core saccharide branch display enhanced MD2 binding, and increased triggering of cytokine production. Interestingly, the <italic toggle="yes">wadC</italic> mutants are also more susceptible to complement and antibacterial cationic peptides &#8211; thus not all the serum resistance reflects O-polysaccharide or Lipid A composition.<xref rid="cit0021" ref-type="bibr"><sup>21,26</sup></xref> Perhaps because of this increased susceptibility, plus the increased immune activation, the <italic toggle="yes">wadC</italic> mutant <italic toggle="yes">Brucella</italic> are attenuated <italic toggle="yes">in vivo</italic> in mice.<xref rid="cit0019" ref-type="bibr"><sup>19</sup></xref> Conversely, the immune evasion properties of wild type <italic toggle="yes">Brucella</italic> LPS contribute to the prevailing conception of <italic toggle="yes">Brucella</italic> as a &#8220;stealthy pathogen&#8221;.<xref rid="cit0027" ref-type="bibr"><sup>27,28</sup></xref></p><p>Nevertheless, there are some challenges to the notion that <italic toggle="yes">Brucella</italic> completely evades TLR4 detection. Although results are conflicting, some studies have documented a role for TLR4 in <italic toggle="yes">Brucella</italic> resistance.<xref rid="cit0029" ref-type="bibr"><sup>29&#8211;31</sup></xref> Adjuvant properties of <italic toggle="yes">Brucella</italic> LPS have been reported.<xref rid="cit0032" ref-type="bibr"><sup>32,33</sup></xref> Most of the studies documenting poor TLR4 stimulation of dendritic cells by <italic toggle="yes">Brucella</italic> LPS have used GM-CSF derived dendritic cells <italic toggle="yes">in vitro</italic>. However, dendritic cell heterogeneity has been increasingly recognized. Just within the spleen, subtypes include plasmacytoid dendritic cells, CD11b+ and CD8a+ conventional dendritic cells, and monocyte-derived dendritic cells.<xref rid="cit0034" ref-type="bibr"><sup>34</sup></xref> These subtypes vary in TLR expression, capacity for viral-induced IFN responses, T-cell costimulation and cross-presentation of external antigen to CD8 T cells. The roles of these different subsets in response to <italic toggle="yes">Brucella</italic> infection have not been clearly defined. The study by Zhao et&#160;al. entitled &#8220;Immunomodulatory properties of <italic toggle="yes">Brucella</italic> melitensis lipopolysaccharide determinants in mouse dendritic cells in vitro and in vivo&#8221; supports the importance of evaluating different dendritic subsets when assessing LPS stimulatory capacity.<xref rid="cit0035" ref-type="bibr"><sup>35</sup></xref></p><p>In this study Zhao et&#160;al employed a &#8220;mix and match&#8221; approach, examining the effect of various purified LPS preparations sharing different features with <italic toggle="yes">Brucella</italic> LPS. For instance <italic toggle="yes">Ochrobactrum anthropi 3331</italic> LPS contains a Lipid A moiety similar to <italic toggle="yes">Brucella</italic>, whereas <italic toggle="yes">Yersinia enterocolitica</italic> O:9 shares a similar O-chain polysaccharide.<xref rid="cit0036" ref-type="bibr"><sup>36,37</sup></xref>
<italic toggle="yes">E. coli</italic> LPS served as the gold standard TLR4 agonist. The ability of these LPS preps to activate different types of dendritic cells, as assessed by cytokine production and cell surface markers (B7 molecules, CD40, MHC class II, PDL-1) were compared <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>. Several notable findings challenge current paradigms:
<list list-type="simple"><list-item><label>1)</label><p>This study emphasized the importance of the <italic toggle="yes">Brucella</italic> core polysaccharide branch: surprisingly, <italic toggle="yes">Brucella</italic>-type lipid A and the O-polysaccharide were not in themselves problematic for TLR4 stimulation, as the <italic toggle="yes">O. anthropi</italic>, <italic toggle="yes">Y enterocolitica</italic> and the <italic toggle="yes">wadC Brucella</italic> mutant induced co-stimulator expression and cytokine production comparable to <italic toggle="yes">E. coli</italic> LPS in GM-CSF derived dendritic cells. Interestingly, only IL-10 production correlated with Lipid A structure. Thus a bulky Lipid A may be less of an issue for pro-inflammatory cytokine induction than previously thought. Indeed, despite the <italic toggle="yes">Brucella</italic>-type Lipid A, <italic toggle="yes">O. anthropi 3331</italic> LPS induced greater production of IL-12p70, TNF-&#945;, IL-6 and IL-1&#946; than equimolar <italic toggle="yes">E. coli</italic> LPS.</p></list-item><list-item><label>2)</label><p><italic toggle="yes">Brucella</italic> LPS is not completely inert: In Fms related tyrosine kinase 3 (Flt3) derived dendritic cells, <italic toggle="yes">Brucella</italic> LPS induces comparable TNF-&#945; secretion and upregulation of MHC class II to other forms of LPS, and significant (though reduced) increases in co-stimulatory molecules. These findings challenge the notion that <italic toggle="yes">Brucella</italic> LPS is a universally poor TLR4 stimulus.</p></list-item></list></p><p>Their results also provide greater insight into how <italic toggle="yes">Brucella</italic> avoids potent activation of adaptive response: <italic toggle="yes">In vitro</italic>, <italic toggle="yes">Brucella</italic> LPS was deficient in stimulating Flt3 dendritic cell production of IL-12p70 and IFN-&#947;, 2 cytokines critical for the Th1 responses that control disease.<xref rid="cit0010" ref-type="bibr"><sup>10,11</sup></xref>
<italic toggle="yes">Brucella</italic> LPS also failed to activate Flt3 dendritic cells sufficiently to support CD4 or CD8 T cell proliferation <italic toggle="yes">in vitro. In vivo</italic>, unlike <italic toggle="yes">E. coli</italic> or the <italic toggle="yes">wadC</italic> mutant LPS, <italic toggle="yes">Brucella</italic> LPS induced very little splenic expansion of CD64+ DC-sign+ monocyte-derived dendritic cells. Interestingly, one of the few activation markers significantly up-regulated on CD11c<sup>hi</sup> spleen cells was programmed death ligand (PDL-1), which would undermine adaptive responses by causing T cell exhaustion.<xref rid="cit0035" ref-type="bibr"><sup>35</sup></xref> Consistent with this observation, CD8 T cell exhaustion has been reported in mouse models of brucellosis.<xref rid="cit0038" ref-type="bibr"><sup>38,39</sup></xref></p><p>Together, the results reported by Zhou et&#160;al. raise compelling questions regarding the nature of TLR4/MD2 recognition of LPS. It is not clear how TLR4/MD2 distinguishes between the individual types of LPS to induce a different cytokine profile. Are there subtle differences in oligomerization or structural conformation that result in altered recruitment of cytosolic adaptors and other signaling molecules? The exact mechanism by which the <italic toggle="yes">Brucella</italic> core polysaccharide branch &#8220;shields&#8221; recognition, as well as how these different bacterial forms of LPS bind the TLR4 receptor complex may require crystallographic definition.</p><p>One of the more intriguing issues raised by this study is the potential to use the <italic toggle="yes">wadC Brucella</italic> mutant as a vaccine. The <italic toggle="yes">wadC</italic> mutant LPS induces similar mobilization of CD11b BST-2+ monocyte derived dendritic cells as <italic toggle="yes">E. coli</italic> LPS and comparable induction of co-stimulatory marker expression, but displays attenuation <italic toggle="yes">in vivo</italic>. These authors have provided initial data that the <italic toggle="yes">wadC</italic> mutant <italic toggle="yes">Brucella</italic> may be at least as protective as the S19 vaccine strain.<xref rid="cit0040" ref-type="bibr"><sup>40</sup></xref> However development of this mutant for vaccine purposes will require greater analysis of the effect of the whole bacteria <italic toggle="yes">in vivo</italic> (not just the LPS) and further exploration of the organism's protective capacity. Safety, particularly as it affects reproduction, will also need to be established.</p></body><back><sec><title>Disclosure of potential conflicts of interest</title><p>No potential conflicts of interest were disclosed.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bosilkovski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsianos</surname><given-names>E</given-names></name></person-group><article-title>Brucellosis</article-title>. <source>N Engl J Med</source><year>2005</year>;<volume>352</volume>:<fpage>2325</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">15930423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra050570</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dean</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Crump</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Greter</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hattendorf</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schelling</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zinsstag</surname><given-names>J</given-names></name></person-group><article-title>Clinical manifestations of human brucellosis: a systematic review and meta-analysis</article-title>. <source>PLoS Negl Trop Dis</source><year>2012</year>;<volume>6</volume>:<fpage>e1929</fpage>.<pub-id pub-id-type="pmid">23236528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pntd.0001929</pub-id><pub-id pub-id-type="pmcid">PMC3516581</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Franco</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Mulder</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gilman</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Smits</surname><given-names>HL</given-names></name></person-group><article-title>Human brucellosis</article-title>. <source>Lancet Infect Dis</source><year>2007</year>;<volume>7</volume>:<fpage>775</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">18045560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(07)70286-4</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Calderon</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Lopez-Merino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Contreras-Rodriguez</surname><given-names>A</given-names></name></person-group><article-title>A history of the development of Brucella vaccines</article-title>. <source>Biomed Res Int</source><year>2013</year>;<volume>2013</volume>:<fpage>743509</fpage>.<pub-id pub-id-type="pmid">23862154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/743509</pub-id><pub-id pub-id-type="pmcid">PMC3686056</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Papadimitriou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Christou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tsianos</surname><given-names>EV</given-names></name></person-group><article-title>The new global map of human brucellosis</article-title>. <source>Lancet Infect Dis</source><year>2006</year>;<volume>6</volume>:<fpage>91</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16439329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(06)70382-6</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Panagopoulou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Christou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name></person-group><article-title>Brucella as a biological weapon</article-title>. <source>Cell Mol Life Sci</source><year>2006</year>;<volume>63</volume>:<fpage>2229</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">16964579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00018-006-6311-4</pub-id><pub-id pub-id-type="pmcid">PMC11136069</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallach</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Ferrero</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Victoria Delpino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Baldi</surname><given-names>PC</given-names></name></person-group><article-title>Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina</article-title>. <source>Clin Microbiol Infect</source><year>2008</year>;<volume>14</volume>:<fpage>805</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">18727806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1469-0691.2008.02029.x</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>F</given-names></name></person-group><article-title>Laboratory-acquired meningitis caused by Brucella abortus strain 19</article-title>. <source>J Infect Dis</source><year>1986</year>;<volume>154</volume>:<fpage>915</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">3095438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/154.5.915</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease C, Prevention</collab></person-group><article-title>Human exposure to Brucella abortus strain RB51&#8211;Kansas, 1997</article-title>. <source>MMWR Morb Mortal Wkly Rep</source><year>1998</year>;<volume>47</volume>:<fpage>172</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">9518281</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clapp</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Skyberg</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Thornburg</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses</article-title>. <source>Infect Immun</source><year>2011</year>;<volume>79</volume>:<fpage>4165</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="pmid">21768283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.05080-11</pub-id><pub-id pub-id-type="pmcid">PMC3187253</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitry</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>De Trez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Goriely</surname><given-names>S</given-names></name>, et&#160;al.</person-group><article-title>Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice</article-title>. <source>Infect Immun</source><year>2012</year>;<volume>80</volume>:<fpage>4271</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">23006848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00761-12</pub-id><pub-id pub-id-type="pmcid">PMC3497404</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maldonado-Lopez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moser</surname><given-names>M</given-names></name></person-group><article-title>Dendritic cell subsets and the regulation of Th1/Th2 responses</article-title>. <source>Semin Immunol</source><year>2001</year>;<volume>13</volume>:<fpage>275</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">11502162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/smim.2001.0323</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lapaque</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>Brucella lipopolysaccharide acts as a virulence factor</article-title>. <source>Curr Opin Microbiol</source><year>2005</year>;<volume>8</volume>:<fpage>60</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15694858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mib.2004.12.003</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erridge</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bennett-Guerrero</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Poxton</surname><given-names>IR</given-names></name></person-group><article-title>Structure and function of lipopolysaccharides</article-title>. <source>Microbes Infect</source><year>2002</year>;<volume>4</volume>:<fpage>837</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">12270731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1286-4579(02)01604-0</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lien</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Golenbock</surname><given-names>DT</given-names></name></person-group><article-title>MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation</article-title>. <source>J Biol Chem</source><year>2010</year>;<volume>285</volume>:<fpage>8695</fpage>&#8211;<lpage>702</lpage>.<pub-id pub-id-type="pmid">20018893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M109.075127</pub-id><pub-id pub-id-type="pmcid">PMC2838292</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klett</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oberhauser</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Perez-Regidor</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Martin-Santamaria</surname><given-names>S</given-names></name></person-group><article-title>Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling</article-title>. <source>Curr Top Med Chem</source><year>2014</year>;<volume>14</volume>:<fpage>2672</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="pmid">25515751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1568026614666141215144831</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Boettcher</surname><given-names>LA</given-names></name></person-group><article-title>Biological activities of Brucella abortus lipopolysaccharides</article-title>. <source>Infect Immun</source><year>1981</year>;<volume>31</volume>:<fpage>362</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="pmid">6783538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.31.1.362-370.1981</pub-id><pub-id pub-id-type="pmcid">PMC351792</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldstein</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Frasch</surname><given-names>C</given-names></name>, et&#160;al.</person-group><article-title>Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines</article-title>. <source>Infect Immun</source><year>1992</year>;<volume>60</volume>:<fpage>1385</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">1548064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.60.4.1385-1389.1992</pub-id><pub-id pub-id-type="pmcid">PMC257008</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name>, et&#160;al.</person-group><article-title>The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition</article-title>. <source>PLoS Pathog</source><year>2012</year>;<volume>8</volume>:<fpage>e1002675</fpage>.<pub-id pub-id-type="pmid">22589715</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1002675</pub-id><pub-id pub-id-type="pmcid">PMC3349745</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mora-Cartin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name>, et&#160;al.</person-group><article-title>Brucella abortus Induces the Premature Death of Human Neutrophils through the Action of Its Lipopolysaccharide</article-title>. <source>PLoS Pathog</source><year>2015</year>;<volume>11</volume>:<fpage>e1004853</fpage>.<pub-id pub-id-type="pmid">25946018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1004853</pub-id><pub-id pub-id-type="pmcid">PMC4422582</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenschenk</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Houle</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>EM</given-names></name></person-group><article-title>Mechanism of serum resistance among Brucella abortus isolates</article-title>. <source>Vet Microbiol</source><year>1999</year>;<volume>68</volume>:<fpage>235</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="pmid">10510042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(99)00075-9</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jimenez de Bagues</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Terraza</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dornand</surname><given-names>J</given-names></name></person-group><article-title>Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence</article-title>. <source>Infect Immun</source><year>2004</year>;<volume>72</volume>:<fpage>2429</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">15039375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.72.4.2429-2433.2004</pub-id><pub-id pub-id-type="pmcid">PMC375206</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mancilla</surname><given-names>M</given-names></name></person-group><article-title>Smooth to Rough Dissociation in Brucella: The Missing Link to Virulence</article-title>. <source>Front Cell Infect Microbiol</source><year>2015</year>;<volume>5</volume>:<fpage>98</fpage>.<pub-id pub-id-type="pmid">26779449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2015.00098</pub-id><pub-id pub-id-type="pmcid">PMC4700419</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontana</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Stahle</surname><given-names>J</given-names></name>, et&#160;al.</person-group><article-title>Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence</article-title>. <source>J Biol Chem</source><year>2016</year>;<volume>291</volume>:<fpage>7727</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="pmid">26867577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M115.701540</pub-id><pub-id pub-id-type="pmcid">PMC4817197</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil-Ramirez</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Palacios-Chaves</surname><given-names>L</given-names></name>, et&#160;al.</person-group><article-title>The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus</article-title>. <source>Microb Pathogen</source><year>2014</year>;<volume>73</volume>:<fpage>53</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">24927935</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micpath.2014.06.002</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez de Tejada</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pizarro-Cerda</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name></person-group><article-title>The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides</article-title>. <source>Infect Immun</source><year>1995</year>;<volume>63</volume>:<fpage>3054</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="pmid">7622230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.63.8.3054-3061.1995</pub-id><pub-id pub-id-type="pmcid">PMC173416</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martirosyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>An evolutionary strategy for a stealthy intracellular Brucella pathogen</article-title>. <source>Immunol Rev</source><year>2011</year>;<volume>240</volume>:<fpage>211</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">21349096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-065X.2010.00982.x</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byndloss</surname><given-names>MX</given-names></name>, <name name-style="western"><surname>Tsolis</surname><given-names>RM</given-names></name></person-group><article-title>Brucella spp. Virulence Factors and Immunity</article-title>. <source>Annu Rev Anim Biosci</source><year>2016</year>;<volume>4</volume>:<fpage>111</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="pmid">26734887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-animal-021815-111326</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Rosinha</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, et&#160;al.</person-group><article-title>Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice</article-title>. <source>Infect Immun</source><year>2004</year>;<volume>72</volume>:<fpage>176</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">14688095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.72.1.176-186.2004</pub-id><pub-id pub-id-type="pmcid">PMC344000</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Copin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>De Baetselier P</surname><given-names>Carlier Y</given-names></name>, <name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Muraille</surname><given-names>E</given-names></name></person-group><article-title>MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection</article-title>. <source>J Immunol</source><year>2007</year>;<volume>178</volume>:<fpage>5182</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="pmid">17404301</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.178.8.5182</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zychlinsky</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name></person-group><article-title>MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus</article-title>. <source>Infect Immun</source><year>2005</year>;<volume>73</volume>:<fpage>5137</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">16041030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.8.5137-5143.2005</pub-id><pub-id pub-id-type="pmcid">PMC1201196</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kianmehr</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Kaboudanian Ardestani</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gharegozlou</surname><given-names>B</given-names></name></person-group><article-title>Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant</article-title>. <source>Iran J Immunol</source><year>2014</year>;<volume>11</volume>:<fpage>189</fpage>&#8211;<lpage>99</lpage>.<pub-id pub-id-type="pmid">25266004</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kianmehr</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Soleimanjahi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ardestani</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Fotouhi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Abdoli</surname><given-names>A</given-names></name></person-group><article-title>Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice</article-title>. <source>Med Microbiol Immunol</source><year>2015</year>;<volume>204</volume>:<fpage>205</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">25187406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00430-014-0356-z</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hey</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>HC</given-names></name></person-group><article-title>Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function</article-title>. <source>J Cell Mol Med</source><year>2012</year>;<volume>16</volume>:<fpage>2611</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22862733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1582-4934.2012.01608.x</pub-id><pub-id pub-id-type="pmcid">PMC4118229</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hanniffy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name>, et&#160;al.</person-group><article-title>Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo</article-title>. <source>Virulence</source><year>2017</year>:<fpage>0</fpage> doi. <pub-id pub-id-type="doi">10.1080/21505594.2017.1386831</pub-id>.<pub-id pub-id-type="pmid">28968180</pub-id><pub-id pub-id-type="pmcid">PMC5955181</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velasco</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bengoechea</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Brandenburg</surname><given-names>K</given-names></name>, et&#160;al.</person-group><article-title>Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance</article-title>. <source>Infect Immun</source><year>2000</year>;<volume>68</volume>:<fpage>3210</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10816465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.68.6.3210-3218.2000</pub-id><pub-id pub-id-type="pmcid">PMC97564</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munoz</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Marin</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name>, et&#160;al.</person-group><article-title>Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9</article-title>. <source>Clin Diagn Lab Immunol</source><year>2005</year>;<volume>12</volume>:<fpage>141</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">15642999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.12.1.141-151.2005</pub-id><pub-id pub-id-type="pmcid">PMC540215</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durward-Diioia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harms</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection</article-title>. <source>Infect Immun</source><year>2015</year>;<volume>83</volume>:<fpage>4759</fpage>&#8211;<lpage>71</lpage>.<pub-id pub-id-type="pmid">26416901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01184-15</pub-id><pub-id pub-id-type="pmcid">PMC4645381</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durward</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Radhakrishnan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Harms</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bareiss</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Magnani</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Splitter</surname><given-names>GA</given-names></name></person-group><article-title>Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of brucellosis</article-title>. <source>PLoS One</source><year>2012</year>;<volume>7</volume>:<fpage>e34925</fpage>.<pub-id pub-id-type="pmid">22558103</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0034925</pub-id><pub-id pub-id-type="pmcid">PMC3338818</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gil-Ramirez</surname><given-names>Y</given-names></name>, et&#160;al.</person-group><article-title>Lipopolysaccharide as a target for brucellosis vaccine design</article-title>. <source>Microbial pathogenesis</source><year>2013</year>;<volume>58</volume>:<fpage>29</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">23219811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micpath.2012.11.011</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>